| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 64.13× | 64.13× | 53.87× | 60.33× | 55.05× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 4.32× | 3.53× | 4.13× | 4.97× | 5.35× | ||
| 1.47× | 1.47× | 1.48× | 1.40× | 1.39× | ||
| 0.95× | 0.95× | 0.83× | 1.12× | 1.04× | ||
| 0.63× | 0.63× | 0.56× | 0.73× | 0.63× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 55.05 | 60.33 | 53.87 | 64.13 | 64.13 | |
| Working Capital Turnover | 5.35 | 4.97 | 4.13 | 3.53 | 4.32 | |
| Asset Turnover | 1.39 | 1.40 | 1.48 | 1.47 | 1.47 | |
| Cash Conversion (CFO/Net Income) | 1.04 | 1.12 | 0.83 | 0.95 | 0.95 | |
| CFO/EBITDA | 0.63 | 0.73 | 0.56 | 0.63 | 0.63 |